We are live on ! Find out more
TLSA icon

Tiziana Life Sciences

22 hedge funds and large institutions have $18M invested in Tiziana Life Sciences in 2020 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

550% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 2

100% more funds holding

Funds holding: 1122 (+11)

80% more capital invested

Capital invested by funds: $10M → $18M (+$8M)

3.72% more ownership

Funds ownership: 1.46%5.18% (+3.7%)

20% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 5

Holders
22
Holders Change
+11
Holders Change %
+100%
% of All Funds
0.44%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
13
Increased
4
Reduced
5
Closed
2
Calls
Puts
Net Calls
Net Calls Change

TLSA Hedge Fund Activity: Q3 2020 in Review

22 of the 4,971 institutional investors tracked by Wall St. Rank reported a position in Tiziana Life Sciences (TLSA) for Q3 2020, worth a combined $18M — up 80% from $10M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new TLSA positions and 2 closed out — a net gain of 11 holders — while 4 added to existing stakes and 5 trimmed.

The largest buyer was HighTower Advisors, adding an estimated $4.31M. The largest seller was Renaissance Technologies, cutting an estimated $621K.

  • 22 institutional investors held Tiziana Life Sciences (TLSA) as of Q3 2020, up from 11 in Q2 2020.
  • Funds reported $18M of Tiziana Life Sciences stock for Q3 2020, up 80% quarter-over-quarter.
  • 13 funds opened new Tiziana Life Sciences positions in Q3 2020 and 2 closed out, a net change of +11 holders.
  • The largest Tiziana Life Sciences buyer in Q3 2020 was HighTower Advisors, an estimated $4.31M added.
  • The largest Tiziana Life Sciences seller in Q3 2020 was Renaissance Technologies, an estimated $621K sold.

Based on aggregated 13F filings for Q3 2020.